The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12625000929404p
Ethics application status
Submitted, not yet approved
Date submitted
28/07/2025
Date registered
27/08/2025
Date last updated
27/08/2025
Date data sharing statement initially provided
27/08/2025
Type of registration
Prospectively registered

Titles & IDs
Public title
TRansplant and Infectious diseases Biobank and rEgistry (TRIBE)
Scientific title
TRansplant and Infectious diseases Biobank and rEgistry (TRIBE)
Secondary ID [1] 314782 0
None
Universal Trial Number (UTN)
Trial acronym
TRIBE
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Solid organ transplantation 338013 0
Transplant-related complications 338014 0
Donor-derived infections 338017 0
Stem cell transplantation 338446 0
Transplant-related infections 338447 0
Condition category
Condition code
Infection 334327 334327 0 0
Other infectious diseases
Surgery 334743 334743 0 0
Other surgery

Intervention/exposure
Study type
Observational
Patient registry
True
Target follow-up duration
12
Target follow-up type
Months
Description of intervention(s) / exposure
The TRIBE is a multicenter clinical registry and biobank which will prospectively collect and store clinical data and samples from transplant recipients. Clinical data and high-quality stored biospecimens will be linked, allowing improvements in the delivery of clinical care and support for translational and basic science research.

TRIBE will collect the following data from transplant recipients: patient demographics, medical history, diagnoses leading to transplant, timing of transplant surgery, previous transplant history, donor details and post-transplant complications.

Samples that may be collected from transplant recipients include bloods, stool, urine, saliva, cerebrospinal fluid, bronchoscopy samples, colonoscopy samples and allograft biopsy samples.

In addition, TRIBE will collect clinical information about organ donors and link to enrolled participants for the purpose of reporting donor-derived infections. A waiver of consent will be sought for organ donors and clinical information about organ donors will be obtained via Donate Life Victoria (DLV).

For transplant recipients, there are two pathways to that data and/or samples can be submitted to the TRIBE: (1) routine collection of data and/or samples at pre-determined times (e.g. pre-transplant, >100 days post-transplant, >12 months post-transplant) and (2) event-driven collection of additional clinical data and/or samples [e.g. at time cytomegalovirus (CMV) disease is diagnosed].
Intervention code [1] 331380 0
Not applicable
Comparator / control treatment
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 341986 0
Rate of consent to contribute data and samples donation to TRIBE as a proportion of transplant recipients approached to participate in the active recruitment arm.
Timepoint [1] 341986 0
Ongoing. Final analysis at study completion.
Primary outcome [2] 341987 0
Rate of patients opting out of contributing data to TRIBE as a proportion of total transplants
Timepoint [2] 341987 0
Ongoing. Final analysis at study completion.
Primary outcome [3] 341988 0
Number and characteristics of people requesting data (i.e. transplant stream, scientific discipline, research institute)
Timepoint [3] 341988 0
Ongoing. Final analysis at study completion.
Secondary outcome [1] 450839 0
Number of sites that have been successfully onboarded onto TRIBE
Timepoint [1] 450839 0
Ongoing. Final analysis at study completion.
Secondary outcome [2] 450840 0
Number of instances TRIBE data as used to inform quality improvement activities or policy
Timepoint [2] 450840 0
Ongoing. Final analysis at study completion.

Eligibility
Key inclusion criteria
All transplant recipients.
Patients who are waitlisted or under evaluation for transplant.
All organ donors
Minimum age
0 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
None

Study design
Purpose
Natural history
Duration
Longitudinal
Selection
Defined population
Timing
Both
Statistical methods / analysis
A range of statistical methods may be used depending on reporting requirements and quality audit activities. Descriptive characteristics of participants and audit metrics (i.e. consent rate, completeness of data) may be presented using median with interquartile range and frequency with percentage. Outcomes may be presented as count and percentage of all participants. Logistic regression may be used to compare those who have had a particular outcome compared to those who did not have the outcome.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
SA,VIC
Recruitment hospital [1] 28156 0
Austin Health - Austin Hospital - Heidelberg
Recruitment hospital [2] 28157 0
The Royal Adelaide Hospital - Adelaide
Recruitment postcode(s) [1] 44366 0
3084 - Heidelberg
Recruitment postcode(s) [2] 44367 0
5000 - Adelaide

Funding & Sponsors
Funding source category [1] 319336 0
Government body
Name [1] 319336 0
Austin Health Department of Infectious Diseases and Immunology Research Fund
Country [1] 319336 0
Australia
Funding source category [2] 319337 0
Charities/Societies/Foundations
Name [2] 319337 0
Austin Health Foundation
Country [2] 319337 0
Australia
Primary sponsor type
Government body
Name
Austin Health
Address
Country
Australia
Secondary sponsor category [1] 321821 0
None
Name [1] 321821 0
Address [1] 321821 0
Country [1] 321821 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 317918 0
Austin Health Human Research Ethics Committee
Ethics committee address [1] 317918 0
Ethics committee country [1] 317918 0
Australia
Date submitted for ethics approval [1] 317918 0
23/02/2024
Approval date [1] 317918 0
Ethics approval number [1] 317918 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 142550 0
Dr Olivia Smibert
Address 142550 0
Austin Hospital, 145 Studley Rd, Heidelberg VIC 3084
Country 142550 0
Australia
Phone 142550 0
+613 9496 6676
Fax 142550 0
Email 142550 0
Contact person for public queries
Name 142551 0
Olivia Smibert
Address 142551 0
Austin Hospital, 145 Studley Rd, Heidelberg VIC 3084
Country 142551 0
Australia
Phone 142551 0
+613 9496 6676
Fax 142551 0
Email 142551 0
Contact person for scientific queries
Name 142552 0
Olivia Smibert
Address 142552 0
Austin Hospital, 145 Studley Road Heidelberg VIC 3084
Country 142552 0
Australia
Phone 142552 0
+613 9496 6676
Fax 142552 0
Email 142552 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
Data may be requested by researchers based at universities, institutions, or companies located in Australia or internationally. Requests are reviewed according to the following criteria: (a) In order to be considered, the project for which data are requested must have ethics approval from a nationally or internationally accredited Human Research Ethics Committee (HREC). (b) Applications for data must be complete (TRIBE Data and Sample Access Form) and the information provided to TRIBE must be consistent with the information presented in the applicants’ HREC application. (c) The research protocol should align with the ethical, legal and practical considerations as stated in TRIBE How to Apply and Condition of Use policy.

Conditions for requesting access:
Access to TRIBE data will only be provided if the TRIBE Data and Sample Access Committee approves the request, the proposed research project has received appropriate ethical approval and a Data Transfer Agreement has been fully executed (for researchers from institutions other than Austin Health).

What individual participant data might be shared?
De-identified individual participant data:
What types of analyses could be done with individual participant data?
Analyses as outlined in the approved Human Research Ethics Application and the TRIBE Data and Sample Application Form.

When can requests for individual participant data be made (start and end dates)?
From:
Time of study commencement

To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
Request submitted in writing to [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.